|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 September 2016 |
|
Main ID: |
NCT02721355 |
|
Date of registration:
|
03/03/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Effect of Chicken Egg Antibody (IgY) on Patients With Chronic Gastritis
|
|
Scientific title:
|
Evaluation of a Health Food Supplement Containing Anti-Helicobacter Pylori Urease IgY Antibody on Patients With Chronic Gastritis in Hanoi, Vietnam |
|
Date of first enrolment:
|
June 2013 |
|
Target sample size:
|
77 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02721355 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Vietnam
| | | | | | | |
|
Contacts
|
|
Name:
|
Khien V Vu, Ph. D |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Dept. of Diagnostic Endoscopy, 108 Military Central Hospital, Hanoi, Vietnam |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with gastritis or gastric ulcer who are positive to H. pylori
Exclusion Criteria:
- People allergic to egg proteins
Age minimum:
2 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Chronic Gastritis Caused by Helicobacter Pylori
|
|
Intervention(s)
|
|
Dietary Supplement: GastimunHP
|
|
Primary Outcome(s)
|
|
Effect of IgY in combination with EAC on Helicobacter pylori eradication in patients with chronic gastritis
[Time Frame: 4 weeks]
|
|
Secondary Outcome(s)
|
|
Effect of IgY in combination with EAC on bloating
[Time Frame: 4 weeks]
|
|
Effect of IgY in combination with EAC on severity of abdominal pain.
[Time Frame: 4 weeks]
|
|
Effect of IgY in combination with EAC on nausea and vomiting
[Time Frame: 4 weeks]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|